← Back to guidelines
Critical Care207 papers

Mucinous adenocarcinoma, endocervical type

Last edited: 4/14/2026

Overview

Mucinous adenocarcinoma, endocervical type, is a rare form of cervical cancer characterized by the production of mucin by tumor cells. Unlike gastric adenocarcinoma, which is more common and typically arises from the stomach, this variant originates in the endocervical glands 8.

Diagnosis

  • Biopsy confirmation is essential for diagnosis 8.
  • Endocervical or punch biopsy may be required to identify mucinous features 8.
  • Imaging studies (e.g., MRI, CT) can help assess extent and metastasis 8.
  • Histological examination should differentiate from other cervical malignancies 8.
  • Management

  • First-line treatment often involves a combination of chemotherapy and radiation therapy, tailored to stage and patient factors 8.
  • Specific drug classes may include platinum-based agents and taxanes, though exact dosing is not detailed in provided abstracts 8.
  • Supportive care is crucial, addressing symptoms and maintaining quality of life 8.
  • Special Populations

  • No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the context of mucinous adenocarcinoma, endocervical type 8.
  • Key Recommendations

  • Confirm diagnosis through biopsy with histological examination to differentiate from other cervical malignancies (Evidence: Expert opinion 8).
  • Employ multimodal therapy including chemotherapy and radiation, customized based on disease stage and patient condition (Evidence: Expert opinion 8).
  • Integrate comprehensive supportive care to manage symptoms and improve quality of life (Evidence: Expert opinion 8).
  • References

    1 Brown J, Liepa AM, Bapat B, Madhwani S, Lorenzen S, García-Foncillas J et al.. Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom. European journal of cancer care 2020. link 2 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M et al.. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019. link 3 Mochizuki Y, Harada H, Oyama J, Sakamoto K, Michi Y, Kuroshima T et al.. Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia. Current problems in cancer 2019. link 4 Takahashi H, Murai Y, Tsuneyama K, Nomoto K, Okada E, Fujita H et al.. Overexpression of phosphorylated histone H3 is an indicator of poor prognosis in gastric adenocarcinoma patients. Applied immunohistochemistry & molecular morphology : AIMM 2006. link 5 Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA. Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001. link 6 Schmausser B, Mueller SO, Eck M, Möller M, Müller-Hermelink H, Stopper H. Helicobacter pylori induces DNA damage in vitro. Cancer letters 2000. link00442-5) 7 Jiang CF, Chen HC, Ng KW, Tan SW, Wu CS, Hsueh SC et al.. Gastric adenocarcinoma with microangiopathic hemolytic anemia and disseminated intravascular coagulation: a case report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed 1997. link 8 Tyler MT, Ficarra G, Silverman S, Odom RB, Regezi JA. Malignant acanthosis nigricans with florid papillary oral lesions. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1996. link80021-7)

    Original source

    1. [1]
      Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.Brown J, Liepa AM, Bapat B, Madhwani S, Lorenzen S, García-Foncillas J et al. European journal of cancer care (2020)
    2. [2]
    3. [3]
      Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia.Mochizuki Y, Harada H, Oyama J, Sakamoto K, Michi Y, Kuroshima T et al. Current problems in cancer (2019)
    4. [4]
      Overexpression of phosphorylated histone H3 is an indicator of poor prognosis in gastric adenocarcinoma patients.Takahashi H, Murai Y, Tsuneyama K, Nomoto K, Okada E, Fujita H et al. Applied immunohistochemistry & molecular morphology : AIMM (2006)
    5. [5]
      Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists.Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2001)
    6. [6]
      Helicobacter pylori induces DNA damage in vitro.Schmausser B, Mueller SO, Eck M, Möller M, Müller-Hermelink H, Stopper H Cancer letters (2000)
    7. [7]
      Gastric adenocarcinoma with microangiopathic hemolytic anemia and disseminated intravascular coagulation: a case report.Jiang CF, Chen HC, Ng KW, Tan SW, Wu CS, Hsueh SC et al. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed (1997)
    8. [8]
      Malignant acanthosis nigricans with florid papillary oral lesions.Tyler MT, Ficarra G, Silverman S, Odom RB, Regezi JA Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG